GLP-1R overexpression can inhibit the expression of inflammatory factors such as IL-6, IL-8, TNF- and granulocyte and macrophage colony-stimulating factor (GM-CSF) by increasing the expression of adenosine triphosphate-binding cassette transporter A1 (ABCA1) and reduce the proliferation and migration of smooth muscle, indicating that GLP-1R can play a protective role in smooth muscle cells and COPD, thereby improving airway inflammation and airflow limitation in COPD patients, providing a basis for the application of GLP-1RA in COPD
Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, and Krumdieck CL (1994)
In clinical settings, IV administration allows glutathione to bypass digestion and enter circulation directly, offering more predictable absorption. According to Patel, IVs can be effective in the short-term, but can create sharp spikes in blood levels that rise quickly and fade just as fast. After years of research, Patel developed a patented sub-nano topical delivery system designed to transport reduced glutathione across the skin barrier and into circulation, which can be found in his Auro Wellness products
10.1182/blood-2006-04-019778 111 MateosM